Fuchs Petrolub SE (DE:FPE)
XETRA:FPE
Want to see DE:FPE full AI Analyst Report?
Top Page
Fuchs Petrolub
(XETRA:FPE)
Select Model
Select Model
Rating:81Outperform
Price Target:
€38.00
▲(19.69% Upside)
Action:ReiteratedDate:05/01/26
The score is driven primarily by strong financial fundamentals (low leverage, solid margins, and strong ROE), supported by positive technical momentum with price above major moving averages. Valuation is reasonable with a ~3.55% dividend yield, but not exceptionally cheap, and growth/cash-flow conversion have shown some variability.
Positive Factors
Conservative balance sheet / low leverage
Very low debt-to-equity (~6% TTM) and steadily growing equity give FUCHS durable financial flexibility. This reduces refinancing risk, supports dividend policy, enables selective M&A or capex during cycles, and preserves resilience through industry downturns.
Negative Factors
Uneven revenue growth / cyclicality
Irregular top-line swings and a year with revenue decline indicate sensitivity to end-market cycles and demand variability. Persistent uneven growth complicates capacity planning, forecasting and sustained margin expansion, raising execution risk across planning horizons.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet / low leverage
Very low debt-to-equity (~6% TTM) and steadily growing equity give FUCHS durable financial flexibility. This reduces refinancing risk, supports dividend policy, enables selective M&A or capex during cycles, and preserves resilience through industry downturns.
Read all positive factors
Fuchs Petrolub (FPE) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€4.70B
Dividend Yield3.91%
Average Volume (3M)43.63K
Price to Earnings (P/E)13.3
Beta (1Y)0.69
Revenue Growth0.03%
EPS Growth5.54%
CountryDE
Employees6,818
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)2.43
Shares Outstanding65,500,000
10 Day Avg. Volume37,158
30 Day Avg. Volume43,631
Financial Highlights & Ratios
PEG Ratio7.48
Price to Book (P/B)2.53
Price to Sales (P/S)1.40
P/FCF Ratio15.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€44.00Price Target Upside38.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)2.44
Revenue Forecast (FY)€3.89B
Fuchs Petrolub Business Overview & Revenue Model
Company Description
Fuchs Petrolub SE develops, produces, and sells lubricants and related specialties worldwide. The company offers automotive lubricants, such as biodegradable lubricants, central and mobile hydraulic oils, dry coatings, engine and gear oils, motorc...
How the Company Makes Money
FUCHS primarily makes money by selling lubricants and lubricant-related specialties to industrial and automotive customers. Its revenue model is predominantly product-based, with sales generated from: (1) Industrial lubricants and specialties supp...
Fuchs Petrolub Earnings Call Summary
Earnings Call Date:Oct 31, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Jul 30, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted a strong recovery in Q3, driven by growth in Asia Pacific and the Americas, successful acquisitions, and sustainability initiatives. However, challenges in Europe, currency headwinds, and a reduction in net liquidity presented some concerns.Positive Updates
Strong Recovery in Q3
FUCHS SE saw a strong recovery in Q3 after a tough second quarter, with EBIT exceeding last year's Q3 results and a sequential improvement of 16%.
Negative Updates
Challenges in Europe
Europe faced a challenging economic situation with weak demand, especially in the automotive manufacturing sector, leading to an organic decline in sales.
Read all updates
Q3-2025 Updates
Positive
Negative
Strong Recovery in Q3
FUCHS SE saw a strong recovery in Q3 after a tough second quarter, with EBIT exceeding last year's Q3 results and a sequential improvement of 16%.
Read all positive updates
Company Guidance
During the third quarter conference call for FUCHS SE, the company reported a 1% increase in sales to EUR 2.7 billion, despite facing a challenging market environment marked by currency effects that negatively impacted revenue by EUR 51 million. The company's EBIT showed positive development, exceeding last year's Q3 results, although the 9-month profitability of EUR 326 million was 2% below the prior year. The growth was driven by a strong business mix in North America, continued expansion in Asia, particularly China, and the initial effects of cost measures implemented in the previous quarter. Free cash flow stood at EUR 181 million, and the company confirmed its 2025 outlook, expecting sales to align with the previous year and EBIT to close at a strong level. The organic growth was mainly supported by the Asia Pacific and Americas regions, which offset a moderate organic decline in EMEA. Furthermore, the company highlighted its strategic investments and acquisitions, such as LUBCON and STRUB, which contributed positively to its growth.Fuchs Petrolub Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.57B | 3.56B | 3.52B | 3.54B | 3.41B | 2.87B |
| Gross Profit | 1.26B | 1.19B | 1.22B | 1.15B | 1.05B | 965.00M |
| EBITDA | 544.00M | 530.00M | 537.00M | 514.00M | 457.00M | 438.00M |
| Net Income | 318.00M | 306.00M | 302.00M | 282.00M | 259.00M | 253.00M |
Balance Sheet | ||||||
| Total Assets | 2.92B | 2.73B | 2.61B | 2.42B | 2.52B | 2.31B |
| Cash, Cash Equivalents and Short-Term Investments | 337.00M | 244.00M | 153.00M | 175.00M | 119.00M | 146.00M |
| Total Debt | 134.00M | 93.00M | 112.00M | 63.00M | 179.00M | 49.00M |
| Total Liabilities | 827.00M | 752.00M | 710.00M | 619.00M | 682.00M | 555.00M |
| Stockholders Equity | 2.08B | 1.98B | 1.90B | 1.80B | 1.84B | 1.75B |
Cash Flow | ||||||
| Free Cash Flow | 357.00M | 314.00M | 307.00M | 460.00M | 59.00M | 89.00M |
| Operating Cash Flow | 441.00M | 406.00M | 390.00M | 543.00M | 128.00M | 169.00M |
| Investing Cash Flow | -101.00M | -117.00M | -185.00M | -82.00M | -69.00M | -108.00M |
| Financing Cash Flow | -200.00M | -190.00M | -228.00M | -400.00M | -86.00M | -132.00M |
Fuchs Petrolub Technical Analysis
Positive
31.75
Price Trends
30.02
Positive
30.09
Positive
30.76
Positive
Market Momentum
0.54
Negative
66.19
Neutral
70.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:FPE, the sentiment is Positive. The current price of 31.75 is above the 20-day moving average (MA) of 30.26, above the 50-day MA of 30.02, and above the 200-day MA of 30.76, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 66.19 is Neutral, neither overbought nor oversold. The STOCH value of 70.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:FPE.
Fuchs Petrolub Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | €4.70B | 13.32 | 16.02% | 3.91% | 0.03% | 5.54% | |
74 Outperform | €1.68B | 23.96 | 27.29% | 1.24% | ― | ― | |
62 Neutral | €8.33B | 86.47 | 3.10% | 8.92% | -7.17% | 19.37% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | €4.74B | 100.12 | -19.52% | 3.75% | ― | ― | |
54 Neutral | €9.07B | -69.34 | 6.03% | 4.30% | -6.56% | -50.65% | |
49 Neutral | €1.58B | -0.96 | -14.66% | 0.59% | -10.89% | -225.99% |
* Basic Materials Sector Average
DE:FPE
Fuchs Petrolub
32.15
-0.64
-1.95%
DE:BNR
Brenntag AG
62.82
5.47
9.53%
DE:EVK
Evonik
17.88
-0.83
-4.43%
DE:LXS
LANXESS
18.34
-7.48
-28.97%
DE:WCH
Wacker Chemie AG
95.50
32.20
50.87%
DE:ACT
AlzChem Group AG
165.30
42.05
34.11%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.